Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With Lu-177-Dotatate in the Phase III NETTER-1 Trial JOURNAL OF CLINICAL ONCOLOGY Strosberg, J., Wolin, E., Chasen, B., Kulke, M., Bushnell, D., Caplin, M., Baum, R. P., Kunz, P., Hobday, T., Hendifar, A., Oberg, K., Sierra, M., Thevenet, T., Margalet, I., Ruszniewski, P., Krenning, E., NETTER-1Study Grp 2018; 36 (25): 2578-+

View details for DOI 10.1200/JCO.2018.78.5865

View details for Web of Science ID 000445669200003